Drug Profile
Epstein Barr virus nRNA
Alternative Names: EBV nanoRNA; EBV nRNA; EBV-nRNA - Lakewood-AmedexLatest Information Update: 28 Jul 2018
Price :
$50
*
At a glance
- Originator Lakewood Amedex
- Class Antisense RNA
- Mechanism of Action Epstein Barr virus replication inhibitors; RNA interference
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Nasopharyngeal cancer
Most Recent Events
- 28 Jul 2018 No recent reports of development identified for phase-I development in Nasopharyngeal-cancer in China (PO)
- 31 May 2013 EBV nRNA is still in phase I development for Nasopharyngeal cancer
- 28 Aug 2009 Phase-I trials in Nasopharyngeal cancer in China (unspecified route)